We demonstrated a link between platelet-derived CXCL4 and CD8+ T cells through MDSCs, but it is likely that other CXCL4-dependent mechanisms, such as effects on endothelial cells and fibroblast activation, also alter CD8+ T-cell infiltration into tumours. The gene discussed is PF4; the disease is neoplasm.